Dive in Biomedical Research Funding Slows Patient Cures
Federal funding for biomedical research has fallen 22 percent since 2003, dramatically slowing the pace of development for new drugs and treatments. A hoped-for remedy is the 21st Century Cures Act, which would set funding levels and speed drug approvals, according to a North Texas panel of doctors and elected officials address. (Dallas Business Journal)
Information about the authors
Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.